outpatient vaginal administration of isosorbide mononitrate for preinduction
DESCRIPTION
my journal presentationdisclaimer: the journal presented is not mine. due credit to the author of the articleTRANSCRIPT
![Page 1: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/1.jpg)
IGUBAN, Majoerie S.
![Page 2: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/2.jpg)
Study ObjectiveTo determine
whether
60 mg administered vaginally is effective for preinduction cervical ripening on an outpatient basis
Isosorbide mononitrate (ISMN)
![Page 3: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/3.jpg)
Background“Ripening”- cervix softens, dilates, and
effacesNitric oxide (NO) NO synthetase (NOS)
3 isoforms Neuronal Inducible Endothelial
Ideal: induce ripening without causing contractions
![Page 4: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/4.jpg)
Material and Methods
Karnataka Institute of Medical Sciences, Hubli
November 2007 to October 20082 groups:
Group A: 50 participants that used 60 mg ISMN tablet
Group B: 50 participants that used a placebo vit C tablet
![Page 5: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/5.jpg)
Material and MethodsParticipants
100 patients with various indications for induction of labor with unripe cervix
pregnant women between 37 and 43 weeks AOG
Singleton pregnancy with fetus in cephalic presentation
Unfavorable cervix willing to participate in the study
![Page 6: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/6.jpg)
Materials and MethodsCervix- ripe if Bishop score was >6 After 48 hours (or earlier if with any
complaints) assessment of Bishop
scoreo Bishop score ≤6: inpatient cervical ripening
(Misoprostol 25µg q6)o Bishop score >6: oxytocin drip
![Page 7: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/7.jpg)
Material and MethodsFailed labor induction: <4cm cervical dilation
and 90% effacement or at least 5 cm (regardless of effacement) after a minimum of 12-18 hours of membrane rupture and oxytocin administration
![Page 8: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/8.jpg)
Results
![Page 9: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/9.jpg)
Results
![Page 10: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/10.jpg)
Results
![Page 11: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/11.jpg)
Results
![Page 12: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/12.jpg)
DiscussionNO donors were tried for the first time before
surgical evacuation of the first trimester pregnancy in the form of vaginal tablet by Thomson et al and intracerically by Arteaga-Troncoso et al.
![Page 13: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/13.jpg)
DiscussionISMN is an effective cervical ripening agent
compared to placeboISMN group:
spontaneous labor Bishop score at 48-hour decrease further ripening shorter admission to delivery interval
![Page 14: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/14.jpg)
Conclusion
Use of NO donors such as ISMN for induction of cervical
ripening at term was more effective than placebo
![Page 15: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/15.jpg)
Critical AppraisalPrimary validity guidelines:
1. Was the assignment of patients to treatment randomized?Yes, randomized stratified was used.
![Page 16: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/16.jpg)
2. Were all patients who entered the trial properly accounted for and attributed at its conclusion?
a)Was follow up complete?Yes, all patients were assessed accordingly.
b) Were patients analyzed in the groups to which they were randomized?
Yes.
![Page 17: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/17.jpg)
Secondary validity guidelines:
1. Were the patients, clinicians, and study personnel “blind” to the treatment? No. the patient was aware of the study.
Part of the inclusion criteria is the willingness of the patients to participate in the study.
![Page 18: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/18.jpg)
2. Were the groups similar at the start of the trial?
Yes. No significant differences were found between the intervention and control groups at baseline.
3. Aside from the experimental intervention, were the groups treated equally?
Yes.
![Page 19: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/19.jpg)
How large was the treatment effect?
Absolute risk reduction: 0.1Relative Risk: 0.7Relative risk reduction: 0.3 (30 %)
![Page 20: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/20.jpg)
Can this be applied to my patient care?Yes
Were all clinically important outcomes considered?Yes. The use of ISMN was proven to be effective as
a cervical ripening agent in an outpatient basis
Are the likely treatment benefits worth the potential harm and costs?Yes
![Page 21: Outpatient Vaginal Administration of Isosorbide Mononitrate for Preinduction](https://reader036.vdocuments.us/reader036/viewer/2022062805/55cf9484550346f57ba2851b/html5/thumbnails/21.jpg)